Announcement for July 23, 2024 at 08:39 PM GMT

THIS IS AN ANNOUNCEMENT FOR THE MSCI GLOBAL STANDARD INDEXES

MSCI ANNOUNCES A CONSULTATION ON A POTENTIAL ENHANCEMENT TO THE MSCI ACWI IMI VIROLOGY INDEX METHODOLOGY

MSCI announced today the launch of a consultation with the investment community on a potential enhancement to the MSCI ACWI IMI Virology Index methodology. MSCI proposes the following enhancement:

Using MSCI Sales Data as a fallback when the company's historical sales are not reported by Evaluate Pharma.

Details on the methodology proposals are available at: https://www.msci.com/index-consultations.

MSCI invites feedback from market participants by September 15, 2024 and will announce the consultation results and implementation timeline (if any) on or before October 15, 2024.

To participate in the consultation, please provide your feedback through an online survey available on: http://www.msci.com/index-consultations/virology_index_enhance_consultation_2024

We value your feedback and questions.
If you would like to speak to a member of our team about any of the items in this communication, please submit a support ticket via the MSCI Online Case Management Portal https://msci.force.com/answers/s/contactsupport
Alternatively, visit Contact Us https://www.msci.com/contact-us for other means to contact MSCI.

THIS IS AN ANNOUNCEMENT FOR THE MSCI GLOBAL STANDARD INDEXES

                                     End of announcement.
                                     Further announcements may occur as needed.